T1DM therapeutics market expected to reach $7.1 billion by 2021

November 24, 2015

Analysis from business intelligence provider GBI Research - Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - states that the global market value for T1DM treatment will rise from $4.2 billion in 2014 to $7.1 billion by 2021, at a robust Compound Annual Growth Rate (CAGR) of 7.9%.

Previous Article
Molecular Dynamics to present revolutionary whole body CZT digital SPECT/CT solution at RSNA meeting
Molecular Dynamics to present revolutionary whole body CZT digital SPECT/CT solution at RSNA meeting

Molecular Dynamics will present its revolutionary whole body CZT digital SPECT/CT solution at the upcoming ...

Next Article
Teledyne DALSA's CMOS X-Ray detector for mammography to be introduced at RSNA 2015 Technical Exhibition
Teledyne DALSA's CMOS X-Ray detector for mammography to be introduced at RSNA 2015 Technical Exhibition

Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology...